中文
| Catalogue |
|
|
| Recommend Products |
HighTide Therapeutics, Inc.
China, Manufacturer, Hits: 62, Updated:6/9/2026
9–10th Floor, Building D, Shenfang Park, Shenzhen-Hong Kong Sci-Tech Innovation Zone, Guangdong |
Company Profile
-
HighTide Therapeutics, Inc. (shturl.c) is a globally integrated, clinical-stage public biopharmaceutical company founded in 2011. It focuses on discovering and developing novel, multifunctional multi-targeted therapeutics for chronic liver, gastrointestinal, metabolic and cardiovascular-kidney-metabolic (CKM) diseases with large unmet medical needs worldwide. Its lead asset HTD1801 (berberine ursodeoxycholate) has secured multiple FDA Fast Track and Orphan Drug designations, covering indications including MASH/NASH, type 2 diabetes, primary sclerosing cholangitis (PSC) and severe hypertriglyceridemia. The company operates R&D and clinical platforms across China and the United States, advancing a diversified pipeline spanning clinical and discovery stages.